We first demonstrated that circ0001955 might competitively bind miR-188-3p to modulate NCAPG2 expression and activate the AKT-mTOR signaling pathway, leading to tumorigenesis and the development of CSCC. This evidence concerns the gene NCAPG2 and skin squamous cell carcinoma.